FasoracetamvsL-Theanine

Fasoracetam upregulates GABA-B receptor (GABA-B1/GABA-B2 heterodimer) expression and function, which is unique among racetams — this receptor upregulation is potentially beneficial for restoring GABAergic sensitivity after prolonged benzodiazepine or phenibut use. It enhances group II metabotropic glutamate receptor (mGluR2/mGluR3) signaling, which modulates presynaptic glutamate release and reduces excitotoxicity. Fasoracetam increases acetylcholine release in the cerebral cortex via modulation of choline acetyltransferase activity and vesicular acetylcholine transporter function. It may also modulate the glutamatergic system through mGluR5. The combination of GABAergic (GABA-B-mediated inhibition), glutamatergic (mGluR modulation), and cholinergic enhancement provides anxiolytic effects alongside cognitive enhancement. Clinical trials focus on ADHD patients with GRM (glutamate receptor) gene variants.

L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1/SLC7A5) and exerts anxiolytic effects through multiple pathways. It increases GABA synthesis by serving as a substrate for glutamate decarboxylase (GAD), elevating inhibitory tone without directly binding GABA-A receptors — avoiding sedation. It modulates serotonin by increasing tryptophan hydroxylase (TPH2) activity and raises dopamine levels in the prefrontal cortex via inhibition of dopamine reuptake. L-Theanine antagonizes glutamate binding at AMPA and kainate receptor subtypes (GluA1-4, GluK1-5), reducing excitatory neurotransmission and excitotoxicity risk. This glutamate antagonism, combined with increased GABA, drives the characteristic increase in alpha brain wave power (8-14 Hz) in the posterior parietal and occipital cortex — the EEG signature of relaxed alertness. When co-administered with caffeine, L-theanine attenuates caffeine-induced increases in blood pressure and anxiety by modulating sympathetic nervous system activation through alpha-2 adrenergic receptor pathways, while caffeine's dopaminergic and adenosine-blocking effects on focus and attention are preserved.